Merck Recent News
Benzinga's Bulls And Bears Of The Week: Merck, Nike, Target And More
Barron's Picks And Pans: GM, Kraft Heinz, Tesla, Under Armour And More
Bulls And Bears Of The Week: Boeing, GM, Pfizer, Starbucks And More
Barron's Picks And Pans: Corning, Merck, Microsoft And More
Ahead Of Earnings: Why You Should Be Buying Merck And Selling Bristol-Myers
Barron's Picks And Pans: Gold, Energy, Dividends And More
Can Merck And Pfizer Beat Low Expectations?
Dow Earnings: High Hopes For Chevron, Johnson & Johnson
This Week's Dow Earnings: High Expectations For DuPont And Visa
Biotech In The Earnings Spotlight: Amgen, Celgene, Gilead Sciences
Merck And Pfizer Earnings: Will They Beat Expectations Again?
Shares Of Merck Dip Lower Following Q4 Print
Merck Confirms FDA Approval Of Hep C Drug At A Cost Of $54,600 Per Patient
Adam Feurestein Reminds Twitter Followers 'Today Is Merck's HepC elbasvir/grazoprevir PDUFA'
Barron's Recap: What's Next?
Barron's Recap: Airline Stocks Ready To Soar
Bank Of America On Merck: 'MAGNIF-TECOS!'
Apple & Other Earnings Expected To Dominate The Week Of April 27
Why Johnson & Johnson's Strong Pharmaceutical Business Is A Concern
Merck Shares Teetering On The Brink Of A Further Downside Correction
Earnings Expectations For The Week Of February 2: Disney, Exxon, GM And More
Earnings Expectations For The Week Of October 27: Facebook, Exxon, Pfizer And Much More
Markets Debut Week On Negative Note; S&P 500 Falls Through Key Level